Peter J Dickinson Selected Research

Peter J Dickinson Research Topics

Disease

12	Neoplasms (Cancer) 05/2024 - 04/2004
10	Glioma (Gliomas) 11/2023 - 05/2010
5	Astrocytoma (Pilocytic Astrocytoma) 09/2023 - 05/2010
4	Meningioma (Meningiomas) 05/2024 - 02/2006
4	Glioblastoma (Glioblastoma Multiforme) 06/2023 - 04/2004
3	Oligodendroglioma 06/2023 - 05/2010
2	Carcinogenesis 05/2024 - 07/2023
2	Brain Diseases (Brain Disorder) 04/2020 - 01/2013
2	Brain Neoplasms (Brain Tumor) 01/2019 - 01/2016
2	Congenital Myasthenic Syndromes (Myasthenia Gravis, Congenital) 12/2015 - 11/2005
1	Hypoxia (Hypoxemia) 11/2023
1	Retinoblastoma (Glioblastoma, Retinal) 12/2022
1	Feline Infectious Peritonitis 07/2020
1	Infections 01/2020
1	COVID-19 01/2020
1	Neuroaxonal Dystrophies (Neuroaxonal Dystrophy, Late Infantile) 01/2018
1	Leukoencephalopathies 01/2018
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2016
1	Pain (Aches) 12/2012
1	Cryptococcosis 08/2011
1	Muscular Dystrophies (Muscular Dystrophy) 12/2008
1	Wounds and Injuries (Trauma) 11/2008
1	Disease Progression 05/2006
1	Blister (Bulla) 05/2006
1	Otitis Media 05/2006
1	Myasthenia Gravis 11/2005

Drug/Important Bio-Agent (IBA)

3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2023 - 05/2006
3	Proteins (Proteins, Gene)FDA Link 12/2022 - 02/2006
2	Antiviral Agents (Antivirals)IBA 07/2020 - 01/2020
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 12/2015 - 11/2005
1	TH 302IBA 11/2023
1	ProdrugsIBA 11/2023
1	Temozolomide (Temodar)FDA LinkGeneric 11/2023
1	Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA 11/2023
1	A-Form DNA (A-DNA)IBA 11/2023
1	Adenosine Triphosphate (ATP)IBA 11/2023
1	Alkylating AgentsIBA 11/2023
1	Transcription Factors (Transcription Factor)IBA 11/2023
1	PlasticsIBA 09/2023
1	Proto-Oncogene Proteins c-metIBA 06/2023
1	Galectins (Galectin)IBA 06/2023
1	PTC-209IBA 12/2022
1	Interleukin-13IBA 01/2021
1	EphA2 ReceptorIBA 01/2021
1	EphrinsIBA 01/2021
1	Ephrin-A1 (Ephrin A1)IBA 01/2021
1	gamma-glutamylaminomethylsulfonic acid (GAMS)IBA 01/2021
1	Interleukin-13 Receptors (Interleukin 13 Receptor)IBA 01/2021
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2021
1	Cytotoxins (Cytolysins)IBA 01/2021
1	tyrosine receptor (receptor, tyrosine)IBA 10/2020
1	Phosphotransferases (Kinase)IBA 10/2020
1	GS-441524IBA 07/2020
1	Adenosine (Adenocard)FDA LinkGeneric 07/2020
1	NucleosidesIBA 07/2020
1	MicroRNAs (MicroRNA)IBA 04/2020
1	Biomarkers (Surrogate Marker)IBA 04/2020
1	Caspase 3 (Caspase-3)IBA 01/2019
1	NAD (NADH)IBA 01/2018
1	Complement System Proteins (Complement)IBA 01/2016
1	Thiamine (Aneurin)FDA Link 01/2013
1	SteroidsIBA 12/2012
1	EndorphinsIBA 12/2012
1	Hormones (Hormone)IBA 12/2012
1	AntigensIBA 08/2011
1	Topoisomerase InhibitorsIBA 09/2010
1	Irinotecan (Camptosar)FDA LinkGeneric 09/2010
1	Platelet-Derived Growth Factor alpha ReceptorIBA 05/2010
1	Dystroglycans (Dystroglycan)IBA 12/2008
1	Capsid Proteins (Capsid Protein)IBA 08/2006
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 05/2006
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2006
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 05/2006
1	GlucocorticoidsIBA 02/2006
1	AntibodiesIBA 11/2005
1	Cholinergic ReceptorsIBA 11/2005
1	Edrophonium (Tensilon)FDA LinkGeneric 11/2005
1	DNA (Deoxyribonucleic Acid)IBA 04/2004
1	CytokinesIBA 04/2004
1	1- (2- (9- octadecenoyloxy)ethyl)- 2- (8- heptadecenyl)- 3- (hydroxyethyl)imidazoliniumIBA 04/2004
1	Liposomes (Liposome)IBA 04/2004
1	CholesterolIBA 04/2004
1	LipidsIBA 04/2004

Therapy/Procedure

8	Therapeutics 05/2024 - 05/2006
2	Radiotherapy 05/2024 - 07/2023
2	Drug Therapy (Chemotherapy) 09/2023 - 01/2016
1	Nerve Block (Nerve Blocks) 11/2008
1	Osteotomy 05/2006